Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase II trial of cetuximab and carboplatin in relapsed platinum-sensitive ovarian cancer and evaluation of epidermal growth factor receptor expression: a Gynecologic Oncology Group study.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II trial of cetuximab and carboplatin in relapsed platinum-sensitive ovarian cancer and evaluation of epidermal growth factor receptor expression: a Gynecologic Oncology Group study.
Phase II trial of cetuximab and carboplatin in relapsed platinum-sensitive ovarian cancer and evaluation of epidermal growth factor receptor expression: a Gynecologic Oncology Group study. Gynecol Oncol. 2008 Mar; 108(3):493-9.
View in:
PubMed
subject areas
Adult
Adult
Aged
Aged
Antibodies, Monoclonal
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Antineoplastic Combined Chemotherapy Protocols
Carboplatin
Carboplatin
Cetuximab
Cetuximab
Drug Administration Schedule
Drug Administration Schedule
Drug Resistance, Neoplasm
Drug Resistance, Neoplasm
ErbB Receptors
ErbB Receptors
Female
Female
Gene Expression Regulation, Neoplastic
Gene Expression Regulation, Neoplastic
Humans
Humans
Infusions, Intravenous
Infusions, Intravenous
Middle Aged
Middle Aged
Neoplasm Recurrence, Local
Neoplasm Recurrence, Local
Neoplasms, Hormone-Dependent
Neoplasms, Hormone-Dependent
Ovarian Neoplasms
Ovarian Neoplasms
Treatment Outcome
Treatment Outcome
authors with profiles
Robert S Mannel